NEWS DETAIL

Opini/Keputusan Mengenai Program Penelitian Pediatrik (PIP): Jyseleca, Figoratinib Maleate, Jenis Keputusan: PM: Keputusan Mengenai Amandemen terhadap Aplikasi PIP yang Disepakati, Area Terapi: Penyakit Muskuloskeletal dan Jaringan Ikat, Nomor PIP: EMA/PE/0000232302

Alfasigma S.p.A.

Informasi Medis July 2, 2026

Isi lengkap artikel

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Produk Terkait Artikel Ini

Produk ini dicocokkan otomatis berdasarkan judul, ringkasan, dan isi artikel.

Pertanyaan Umum

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Beli Online.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.